Two lights flashed, one to a mouse’s left and one to its right. To earn a sip of sugar water, the mouse had to pick the side programmed to flash more often. Mice given psilocybin or a moderate dose of ketamine took longer to choose and picked the correct side more often.

The findings, reported November 20 in Science Advances, give researchers a way to explore whether these drugs might help people with depression break out of repetitive patterns of thinking. “These findings reveal how psychedelics reduce the reliance on habits and repetitive choices, which may explain part of their therapeutic effect,” said Benjamin Scott, a Boston University neuroscientist who co-led the study, in a university statement.

Scott co-led the study with fellow Boston University neuroscientist Steve Ramirez. Their team tested 42 mice with psilocybin and 30 with ketamine, comparing each animal’s performance with its own on days it received a saltwater injection. The mice could choose as soon as they liked, even after just a few flashes. Sometimes they favored one side regardless of the lights or went back to the side that had just paid off.

With psilocybin or at moderate doses of ketamine, the flashes carried more weight in the animals’ choices, the team’s analysis suggested. The mice appeared to wait for more evidence before committing. In the paper’s discussion, the researchers describe the shift as “prioritizing cautious, sensory-guided inference over speed or habit.” At the highest ketamine dose tested, the mice slowed down without getting more answers right.

The experiment measured immediate effects on one kind of choice in mice. Whether people would make similar trade-offs, or whether that shift helps explain the drugs’ effects in therapy, remains open. But in six mice, recordings from a brain region involved in weighing choices picked up a change that tracked the slower decisions. The burst of activity around the moment of choice came later, giving researchers a place to look for how the drugs alter the timing of a decision.

The research

Psychedelics shift decision strategies and reconfigure orbitofrontal dynamics ↗

C. Delgado-Sallent, S. A. Ahmed, A. Khawaja-Lopez, B. S. Lee, U. Mishra, R. A. Senne, S. Ramirez and B. B. Scott

Science Advances · Published

DOI: 10.1126/sciadv.aeb3041

A little science for your everyday life.

Get our week’s most surprising stories about health, food and the world around you—in one free email.

Send me the weekly roundup